Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Random, Open Label, Active Comparator-controlled Parallel Study to Evaluate the Efficacy of Nifedipine Controlled-released Tablets (Xin Ran) in Patients With Mild to Moderate Essential Hypertension

NCT02031861 is registered in ClinicalTrials.gov with Shanghai Shyndec Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02031861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02031861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Random, Open Label, Active Comparator-controlled Parallel Study to Evaluate the Efficacy of Nifedipine Controlled-released Tablets (Xin Ran) in Patients With Mild to Moderate Essential Hypertension
Lead sponsor
Shanghai Shyndec Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2014
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension